MedPath

Acetylcysteine

These highlights do not include all the information needed to use ACETYLCYSTEINE INJECTION safely and effectively. See full prescribing information for ACETYLCYSTEINE INJECTION.ACETYLCYSTEINE injection, for intravenous use Initial U.S. Approval: 2004

Approved
Approval ID

4072b547-c242-4a40-8c91-5481b86cbf1e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 16, 2022

Manufacturers
FDA

Akorn

DUNS: 117693100

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acetylcysteine

PRODUCT DETAILS

NDC Product Code17478-660
Application NumberANDA203173
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMarch 27, 2015
Generic NameAcetylcysteine

INGREDIENTS (4)

WaterInactive
Code: 059QF0KO0R
Classification: IACT
AcetylcysteineActive
Quantity: 200 mg in 1 mL
Code: WYQ7N0BPYC
Classification: ACTIB
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Edetate DisodiumInactive
Quantity: 0.5 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acetylcysteine - FDA Drug Approval Details